glutathione and triple negative breast cancer Frontiers Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven
Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Oncology Letters A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple negative breast cancer treatment ScienceDirect
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14




